Discontinuation of Renin–Angiotensin System Inhibitors During the Early Stage of the COVID-19 Pandemic

Muntner, P., Foti, K., Wang, Z., Alanaeme, C. J., Choi, E., Bress, A. P., Shimbo, D., & Kronish, I. (2023). Discontinuation of Renin–Angiotensin System Inhibitors During the Early Stage of the COVID-19 Pandemic. American Journal of Hypertension, 36(7), 404–410. https://doi.org/10.1093/ajh/hpad027
Authors:
Paul Muntner
Kathryn Foti
Zhixin Wang
Chibuike J. Alanaeme
Eunhee Choi
Adam P. Bress
Daichi Shimbo
Ian Kronish
Affiliated Authors:
Eunhee Choi
Daichi Shimbo
Ian Kronish
Columbia Affiliation:
Subjects:
Coronavirus Disease 2019 (OpenAlex Topic)
Impact of COVID-19 on Cancer Patients and Care (OpenAlex Topic)
Impact of COVID-19 on Mental Health (OpenAlex Topic)
COVID-19 (MeSH)
Author Keywords:
19
covid
angiotensin system inhibitors
blood pressure
hypertension
renin
treatment discontinuation
covid-19
renin–angiotensin system inhibitors
elink
Publication Type:
Article
Unique ID:
10.1093/ajh/hpad027
PMID:
36960855
DOI:
10.1093/ajh/hpad027
Journal:
American Journal of Hypertension
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View OpenAlex Record

Record Created: